The addition of nab-paclitaxel to gemcitabine and cisplatin did not improve survival in advanced biliary tract cancer.

February is National Cancer Awareness Month, a time to amplify discussions on lesser- known but equally devastating ...

Gallbladder cancer is a highly aggressive condition with vague symptoms, often leading to late diagnosis. Risk factors ...

Obesity and biliary tract cancers: Changing epidemiology. Transarterial chemoembolization (TACE) combined with camrelizumab and apatinib versus TACE alone in the treatment of unresectable ...

T-DM1 was tolerable in HER2-positive biliary tract adenocarcinoma but did not significantly improve progression-free survival ...

The application to the Ministry of Health, Labour and Welfare (MHLW) is set for a priority review, reflecting the relatively high incidence of biliary tract cancer in Japan relative to other ...

MSD’s PD-1 inhibitor Keytruda has been approved by the FDA as a treatment for locally advanced unresectable or metastatic biliary tract cancer (BTC) in combination with chemotherapy, the first ...

Biliary tract disease describes any disease that affects the biliary tract the gall bladder, bile ducts and accompanying structures. Examples include primary sclerosing cholangitis, secondary ...

The phase 3 NIAGARA trial randomised 1,063 MIBC patients to receive Imfinzi plus neoadjuvant chemotherapy prior to bladder ...

When stage 4 pancreatic cancer progresses through metastasis to abdominal organs and potentially spreads to distant sites ...

Gastrointestinal cancer refers to malignant conditions of the gastrointestinal (GI) tract and other organs involved in digestion, including the oesophagus, stomach, biliary system, pancreas ...

Beyond improving accuracy, xAI allowed researchers to compare prognostic markers across different cancer types, unveiling ...